DJ1, also known as Parkinson disease protein 7, is a protein which in humans is encoded by the PARK7 gene.[5] Its weak glyoxalase activity has been verified by many labs,[6][7] however the reported protein deglycase activity is likely to be an artifact stemming from DJ-1’s ability to destroy free methylglyoxal.
Structure
Gene
The gene PARK7, also known as DJ-1, encodes a protein of the peptidase C56 family. The human gene PARK7 has 8 exons and locates at chromosome band 1p36.23.[5]
Protein
The human protein DJ-1 is 20 kDa in size and composed of 189 amino acids with seven β-strands and nine α-helices in total and is present as a dimer.[8][9][10] It belongs to the peptidase C56 family of proteins.
The protein structures of human protein DJ-1, Escherichia coli chaperone Hsp31, YhbO, and YajL and an Archaea protease are evolutionarily conserved.[11]
Function
DJ-1 was shown to prevent metabolite and protein damage caused by a glycolytic metabolite.[12] This metabolite has been suggested[12] and confirmed[13] to be cyclic 3-phosphoglycerate (or cyclic 3-phosphoglyceric anhydride). Catalytic efficiency of DJ-1 as a hydrolase of cyclic 3-phosphoglyceric anhydride is 10,000 times higher than other reported enzymatic activities of DJ-1.[13]
Under an oxidative condition, DJ-1 inhibits the aggregation of α-synuclein via its chaperone activity,[14][15] thus functioning as a redox-sensitive chaperone and as a sensor for oxidative stress. Accordingly, DJ-1 apparently protects neurons against oxidative stress and cell death.[5] In parallel, protein DJ-1 acts as a positive regulator of androgen receptor-dependent transcription. DJ-1 is expressed in both the neural retina and retinal pigment epithelium of mammals, where it exerts a neuroprotective role against oxidative stress under both physiological and pathological conditions.[16][17]
Pyrroloquinoline quinone (PQQ) has been shown to reduce the self-oxidation of the DJ-1 protein, an early step in the onset of some forms of Parkinson’s disease.[18]
Functional DJ-1 protein has been shown to bind metals and protect against metal-induced cytotoxicity from copper and mercury.[19]
DJ-1/PARK7 and its bacterial homologs: Hsp31, YhbO, and YajL can repair methylglyoxal and glyoxal glycated nucleotides.[20] Guanine, either in the form of a free nucleotide or as a nucleotide incorporated into nucleic acid (DNA or RNA), if glycated, can be repaired by DJ-1/PARK7.[20] Deglycase-deficient bacterial mutants with reduced ability to repair glycated bases in DNA show strong mutator phenotypes.[20] A follow up study confirmed that DJ-1 reduces levels of reversible adducts of methylglyoxal with guanine and cysteine in vitro. However, since the steady-state kinetics of DJ-1 acting on reversible hemithioacetal substrates are fitted adequately with a computational kinetic model that requires only a DJ-1 glyoxalase activity, it was concluded that deglycation is an apparent rather than a true activity of DJ-1.[21]
DNA repair
DJ-1 is a DNA damage response protein that is recruited to sites of DNA damage where it participates in the repair of DNA double-strand breaks through the processes of non-homologous end joining and homologous recombination.[22] Evidence for a linkage between DNA damage and Parkinson’s disease has been reported for decades.[22] Recently evidence has been presented that defective DNA repair is linked specifically to DJ-1 mutation, and thus DJ-1 mutation likely contributes to Parkinson’s disease pathogenesis.[22]
Clinical significance
Defects in this gene are the cause of autosomal recessive early-onset Parkinson’s disease 7.[5][23]
Interactions
PARK7 has been shown to interact with:
See also
References
- ^ a b c GRCh38: Ensembl release 89: ENSG00000116288 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000028964 – Ensembl, May 2017
- ^ “Human PubMed Reference:”. National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ “Mouse PubMed Reference:”. National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ a b c d “Entrez Gene: PARK7”.
- ^ Andreeva A, Bekkhozhin Z, Omertassova N, Baizhumanov T, Yeltay G, Akhmetali M, et al. (December 2019). “The apparent deglycase activity of DJ-1 results from the conversion of free methylglyoxal present in fast equilibrium with hemithioacetals and hemiaminals”. The Journal of Biological Chemistry. 294 (49): 18863–18872. doi:10.1074/jbc.RA119.011237. PMC 6901308. PMID 31653696.
- ^ Choi J, Tak S, Jung HM, Cha S, Hwang E, Lee D, et al. (May 2023). “Kinetic evidence in favor of glyoxalase III and against deglycase activity of DJ-1”. Protein Science. 32 (5) e4641. doi:10.1002/pro.4641. PMC 10127264. PMID 37060572.
- ^ “Uniprot: Q99497 – PARK7_HUMAN”. UniProt.
- ^ Honbou K, Suzuki NN, Horiuchi M, Niki T, Taira T, Ariga H, et al. (August 2003). “The crystal structure of DJ-1, a protein related to male fertility and Parkinson’s disease”. The Journal of Biological Chemistry. 278 (33): 31380–31384. doi:10.1074/jbc.M305878200. PMID 12796482.
- ^ Tao X, Tong L (August 2003). “Crystal structure of human DJ-1, a protein associated with early onset Parkinson’s disease”. The Journal of Biological Chemistry. 278 (33): 31372–31379. doi:10.1074/jbc.M304221200. PMID 12761214.
- ^ Lee SJ, Kim SJ, Kim IK, Ko J, Jeong CS, Kim GH, et al. (November 2003). “Crystal structures of human DJ-1 and Escherichia coli Hsp31, which share an evolutionarily conserved domain”. The Journal of Biological Chemistry. 278 (45): 44552–44559. doi:10.1074/jbc.M304517200. PMID 12939276.
- ^ a b Heremans IP, Caligiore F, Gerin I, Bury M, Lutz M, Graff J, et al. (January 2022). “Parkinson’s disease protein PARK7 prevents metabolite and protein damage caused by a glycolytic metabolite”. Proceedings of the National Academy of Sciences of the United States of America. 119 (4) e2111338119. Bibcode:2022PNAS..11911338H. doi:10.1073/pnas.2111338119. PMC 8795555. PMID 35046029.
- ^ a b Akhmadi A, Yeskendir A, Dey N, Mussakhmetov A, Shatkenova Z, Kulyyassov A, et al. (March 2024). “DJ-1 protects proteins from acylation by catalyzing the hydrolysis of highly reactive cyclic 3-phosphoglyceric anhydride”. Nature Communications. 15 (1) 2004. Bibcode:2024NatCo..15.2004A. doi:10.1038/s41467-024-46391-9. PMC 10915168. PMID 38443379.
- ^ Shendelman S, Jonason A, Martinat C, Leete T, Abeliovich A (November 2004). “DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation”. PLoS Biology. 2 (11) e362. doi:10.1371/journal.pbio.0020362. PMC 521177. PMID 15502874.
- ^ Zhou W, Zhu M, Wilson MA, Petsko GA, Fink AL (March 2006). “The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein”. Journal of Molecular Biology. 356 (4): 1036–1048. doi:10.1016/j.jmb.2005.12.030. PMID 16403519.
- ^ Martín-Nieto J, Uribe ML, Esteve-Rudd J, Herrero MT, Campello L (August 2019). “A role for DJ-1 against oxidative stress in the mammalian retina”. Neuroscience Letters. 708 134361. doi:10.1016/j.neulet.2019.134361. hdl:10045/94474. PMID 31276729. S2CID 195813073.
- ^ Shadrach KG, Rayborn ME, Hollyfield JG, Bonilha VL (2013). “DJ-1-dependent regulation of oxidative stress in the retinal pigment epithelium (RPE)”. PLOS ONE. 8 (7) e67983. Bibcode:2013PLoSO…867983S. doi:10.1371/journal.pone.0067983. PMC 3699467. PMID 23844142.
- ^ Nunome K, Miyazaki S, Nakano M, Iguchi-Ariga S, Ariga H (July 2008). “Pyrroloquinoline quinone prevents oxidative stress-induced neuronal death probably through changes in oxidative status of DJ-1”. Biological & Pharmaceutical Bulletin. 31 (7): 1321–1326. doi:10.1248/bpb.31.1321. hdl:2115/53726. PMID 18591768.
- ^ Björkblom B, Adilbayeva A, Maple-Grødem J, Piston D, Ökvist M, Xu XM, et al. (2013). “Parkinson disease protein DJ-1 binds metals and protects against metal-induced cytotoxicity”. The Journal of Biological Chemistry. 288 (31): 22809–22820. doi:10.1074/jbc.M113.482091. PMC 3829365. PMID 23792957.
- ^ a b c Richarme G, Liu C, Mihoub M, Abdallah J, Leger T, Joly N, et al. (July 2017). “Guanine glycation repair by DJ-1/Park7 and its bacterial homologs”. Science. 357 (6347). New York, N.Y.: 208–211. Bibcode:2017Sci…357..208R. doi:10.1126/science.aag1095. PMID 28596309.
- ^ Mazza MC, Shuck SC, Lin J, Moxley MA, Termini J, Cookson MR, et al. (August 2022). “DJ-1 is not a deglycase and makes a modest contribution to cellular defense against methylglyoxal damage in neurons”. Journal of Neurochemistry. 162 (3): 245–261. doi:10.1111/jnc.15656. PMC 9539984. PMID 35713360.
- ^ a b c Wang ZX, Liu Y, Li YL, Wei Q, Lin RR, Kang R, et al. (May 2023). “Nuclear DJ-1 Regulates DNA Damage Repair via the Regulation of PARP1 Activity”. International Journal of Molecular Sciences. 24 (10): 8651. doi:10.3390/ijms24108651. PMC 10218208. PMID 37239999.
- ^ Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, et al. (January 2003). “Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism”. Science. 299 (5604). New York, N.Y.: 256–259. Bibcode:2003Sci…299..256B. doi:10.1126/science.1077209. PMID 12446870. S2CID 27186691.
- ^ Mukherjee K, Slawson JB, Christmann BL, Griffith LC (2014). “Neuron-specific protein interactions of Drosophila CASK-β are revealed by mass spectrometry”. Frontiers in Molecular Neuroscience. 7 58. doi:10.3389/fnmol.2014.00058. PMC 4075472. PMID 25071438.
- ^ Niki T, Takahashi-Niki K, Taira T, Iguchi-Ariga SM, Ariga H (February 2003). “DJBP: a novel DJ-1-binding protein, negatively regulates the androgen receptor by recruiting histone deacetylase complex, and DJ-1 antagonizes this inhibition by abrogation of this complex”. Molecular Cancer Research. 1 (4): 247–261. PMID 12612053.
- ^ Takahashi K, Taira T, Niki T, Seino C, Iguchi-Ariga SM, Ariga H (October 2001). “DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor”. The Journal of Biological Chemistry. 276 (40): 37556–37563. doi:10.1074/jbc.M101730200. PMID 11477070.
Further reading
- Cookson MR (January 2003). “Pathways to Parkinsonism”. Neuron. 37 (1): 7–10. doi:10.1016/S0896-6273(02)01166-2. PMID 12526767. S2CID 14513509.
- Bonifati V, Oostra BA, Heutink P (March 2004). “Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson’s disease”. Journal of Molecular Medicine. 82 (3). Berlin, Germany: 163–174. doi:10.1007/s00109-003-0512-1. PMID 14712351. S2CID 32685319.
- Le W, Appel SH (February 2004). “Mutant genes responsible for Parkinson’s disease”. Current Opinion in Pharmacology. 4 (1): 79–84. doi:10.1016/j.coph.2003.09.005. PMID 15018843.
- Abou-Sleiman PM, Healy DG, Wood NW (October 2004). “Causes of Parkinson’s disease: genetics of DJ-1”. Cell and Tissue Research. 318 (1): 185–188. doi:10.1007/s00441-004-0922-6. PMID 15503154. S2CID 9453283.
- Pankratz N, Foroud T (April 2004). “Genetics of Parkinson disease”. NeuroRx. 1 (2): 235–242. doi:10.1602/neurorx.1.2.235. PMC 534935. PMID 15717024.
- Heutink P (2006). “PINK-1 and DJ-1 — new genes for autosomal recessive Parkinson’s disease”. Parkinson’s Disease and Related Disorders. Journal of Neural Transmission. Supplementa. Vol. 70. pp. 215–219. doi:10.1007/978-3-211-45295-0_33. ISBN 978-3-211-28927-3. PMID 17017532.
- Lev N, Roncevic D, Roncevich D, Ickowicz D, Melamed E, Offen D (2007). “Role of DJ-1 in Parkinson’s disease”. Journal of Molecular Neuroscience. 29 (3): 215–225. doi:10.1385/JMN:29:3:215. PMID 17085780. S2CID 85481215.
- Nagakubo D, Taira T, Kitaura H, Ikeda M, Tamai K, Iguchi-Ariga SM, et al. (February 1997). “DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras”. Biochemical and Biophysical Research Communications. 231 (2): 509–513. doi:10.1006/bbrc.1997.6132. PMID 9070310.
- Taira T, Takahashi K, Kitagawa R, Iguchi-Ariga SM, Ariga H (January 2001). “Molecular cloning of human and mouse DJ-1 genes and identification of Sp1-dependent activation of the human DJ-1 promoter”. Gene. 263 (1–2): 285–292. doi:10.1016/S0378-1119(00)00590-4. PMID 11223268.
- van Duijn CM, Dekker MC, Bonifati V, Galjaard RJ, Houwing-Duistermaat JJ, Snijders PJ, et al. (September 2001). “Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36”. American Journal of Human Genetics. 69 (3): 629–634. doi:10.1086/322996. PMC 1235491. PMID 11462174.
- Bonifati V, Dekker MC, Vanacore N, Fabbrini G, Squitieri F, Marconi R, et al. (September 2002). “Autosomal recessive early onset parkinsonism is linked to three loci: PARK2, PARK6, and PARK7”. Neurological Sciences. 23 (Suppl 2): S59–60. doi:10.1007/s100720200069. PMID 12548343. S2CID 13625056.
- Dekker M, Bonifati V, van Swieten J, Leenders N, Galjaard RJ, Snijders P, et al. (July 2003). “Clinical features and neuroimaging of PARK7-linked parkinsonism”. Movement Disorders. 18 (7): 751–757. doi:10.1002/mds.10422. PMID 12815653. S2CID 44253517.
- Miller DW, Ahmad R, Hague S, Baptista MJ, Canet-Aviles R, McLendon C, et al. (September 2003). “L166P mutant DJ-1, causative for recessive Parkinson’s disease, is degraded through the ubiquitin-proteasome system”. The Journal of Biological Chemistry. 278 (38): 36588–36595. doi:10.1074/jbc.M304272200. PMID 12851414.
External links
- Overview of all the structural information available in the PDB for UniProt: Q99497 (Protein/nucleic acid deglycase DJ-1) at the PDBe-KB.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.